Literature DB >> 19828435

Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct.

Jayvardhan Pandit1, Michael D Forman, Kimberly F Fennell, Keith S Dillman, Frank S Menniti.   

Abstract

We report the X-ray crystal structure of a phosphodiesterase (PDE) that includes both catalytic and regulatory domains. PDE2A (215-900) crystallized as a dimer in which each subunit had an extended organization of regulatory GAF-A and GAF-B and catalytic domains connected by long alpha-helices. The subunits cross at the GAF-B/catalytic domain linker, and each side of the dimer contains in series the GAF-A and GAF-B of one subunit and the catalytic domain of the other subunit. A dimer interface extends over the entire length of the molecule. The substrate binding pocket of each catalytic domain is occluded by the H-loop. We deduced from comparisons with structures of isolated, ligand-bound catalytic subunits that the H-loop swings out to allow substrate access. However, in dimeric PDE2A (215-900), the H-loops of the two catalytic subunits pack against each other at the dimer interface, necessitating movement of the catalytic subunits to allow for H-loop movement. Comparison of the unliganded GAF-B of PDE2A (215-900) with previous structures of isolated, cGMP-bound GAF domains indicates that cGMP binding induces a significant shift in the GAF-B/catalytic domain linker. We propose that cGMP binding to GAF-B causes movement, through this linker region, of the catalytic domains, such that the H-loops no longer pack at the dimer interface and are, instead, free to swing out to allow substrate access. This increase in substrate access is proposed as the basis for PDE2A activation by cGMP and may be a general mechanism for regulation of all PDEs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828435      PMCID: PMC2775329          DOI: 10.1073/pnas.0907635106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Cyclic GMP phosphodiesterase-5: target of sildenafil.

Authors:  J D Corbin; S H Francis
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

2.  Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7.

Authors:  Huanchen Wang; Yudong Liu; Yuxiang Chen; Howard Robinson; Hengming Ke
Journal:  J Biol Chem       Date:  2005-07-01       Impact factor: 5.157

Review 3.  Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling.

Authors:  Marco Conti; Joseph Beavo
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

4.  Intrinsically disordered gamma-subunit of cGMP phosphodiesterase encodes functionally relevant transient secondary and tertiary structure.

Authors:  Jikui Song; Lian-Wang Guo; Hakim Muradov; Nikolai O Artemyev; Arnold E Ruoho; John L Markley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

5.  The structure of the GAF A domain from phosphodiesterase 6C reveals determinants of cGMP binding, a conserved binding surface, and a large cGMP-dependent conformational change.

Authors:  Sergio E Martinez; Clemens C Heikaus; Rachel E Klevit; Joseph A Beavo
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

6.  Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development.

Authors:  Huanchen Wang; Yudong Liu; Qing Huai; Jiwen Cai; Roya Zoraghi; Sharron H Francis; Jackie D Corbin; Howard Robinson; Zhongcheng Xin; Guiting Lin; Hengming Ke
Journal:  J Biol Chem       Date:  2006-05-30       Impact factor: 5.157

7.  cAMP is a ligand for the tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11.

Authors:  Marco Gross-Langenhoff; Karina Hofbauer; Jost Weber; Anita Schultz; Joachim E Schultz
Journal:  J Biol Chem       Date:  2005-12-05       Impact factor: 5.157

8.  Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.

Authors:  André Iffland; Darcy Kohls; Simon Low; Jing Luan; Yan Zhang; Michael Kothe; Qing Cao; Ajith V Kamath; Yuan-Hua Ding; Tom Ellenberger
Journal:  Biochemistry       Date:  2005-06-14       Impact factor: 3.162

9.  Structural insight into substrate specificity of phosphodiesterase 10.

Authors:  Huanchen Wang; Yudong Liu; Jing Hou; Meiyan Zheng; Howard Robinson; Hengming Ke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

10.  Crystal structure of the tandem GAF domains from a cyanobacterial adenylyl cyclase: modes of ligand binding and dimerization.

Authors:  Sergio E Martinez; Sandra Bruder; Anita Schultz; Ning Zheng; Joachim E Schultz; Joseph A Beavo; Jürgen U Linder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-11       Impact factor: 11.205

View more
  61 in total

1.  Activation of PDE10 and PDE11 phosphodiesterases.

Authors:  Ronald Jäger; Corina Russwurm; Frank Schwede; Hans-Gottfried Genieser; Doris Koesling; Michael Russwurm
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

2.  Characterization of conformational changes and protein-protein interactions of rod photoreceptor phosphodiesterase (PDE6).

Authors:  Suzanne L Matte; Thomas M Laue; Rick H Cote
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

3.  Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference.

Authors:  Natalia Beloglazova; Pierre Petit; Robert Flick; Greg Brown; Alexei Savchenko; Alexander F Yakunin
Journal:  EMBO J       Date:  2011-10-18       Impact factor: 11.598

Review 4.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 5.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

6.  Structural requirements of the photoreceptor phosphodiesterase gamma-subunit for inhibition of rod PDE6 holoenzyme and for its activation by transducin.

Authors:  Xiu-Jun Zhang; Nikolai P Skiba; Rick H Cote
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

7.  A phosphodiesterase 2A isoform localized to mitochondria regulates respiration.

Authors:  Rebeca Acin-Perez; Michael Russwurm; Kathrin Günnewig; Melanie Gertz; Georg Zoidl; Lavoisier Ramos; Jochen Buck; Lonny R Levin; Joachim Rassow; Giovanni Manfredi; Clemens Steegborn
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

8.  First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.

Authors:  Mika Naganawa; Rikki N Waterhouse; Nabeel Nabulsi; Shu-Fei Lin; David Labaree; Jim Ropchan; Sanela Tarabar; Nicholas DeMartinis; Adam Ogden; Anindita Banerjee; Yiyun Huang; Richard E Carson
Journal:  J Nucl Med       Date:  2016-04-21       Impact factor: 10.057

9.  The upstream conserved regions (UCRs) mediate homo- and hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s).

Authors:  Moses Xie; Brigitte Blackman; Colleen Scheitrum; Delphine Mika; Elise Blanchard; Tao Lei; Marco Conti; Wito Richter
Journal:  Biochem J       Date:  2014-05-01       Impact factor: 3.857

Review 10.  Cyclic nucleotide binding GAF domains from phosphodiesterases: structural and mechanistic insights.

Authors:  Clemens C Heikaus; Jayvardhan Pandit; Rachel E Klevit
Journal:  Structure       Date:  2009-12-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.